Literature DB >> 16014558

Autoimmune nature of influenza atherogenicity.

Victor S Gurevich1, Vladimir M Pleskov, Margarita V Levaya.   

Abstract

It has been observed during influenza epidemics and in a number of population and clinical trials that this prevalent viral infection was associated with increased death rates from cardiovascular diseases. The clinical and experimental data that may explain accelerated coronary atherosclerosis in influenza infection with implications involving autoimmune mechanisms are analyzed in this article. Both cellular and humoral autoimmune modes could be proposed to participate in the onset or progression of atheromatous lesions due to influenza infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014558     DOI: 10.1196/annals.1313.092

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Endothelial cell death and intimal foam cell accumulation in the coronary artery of infected hypercholesterolemic minipigs.

Authors:  Malene M Birck; Antti Saraste; Poul Hyttel; Michal Odermarsky; Petru Liuba; Pekka Saukko; Axel K Hansen; Erkki Pesonen
Journal:  J Cardiovasc Transl Res       Date:  2013-04-12       Impact factor: 4.132

2.  Influenza vaccine for cardiovascular risk reduction.

Authors:  Patricia A Howard; James W Kleoppel
Journal:  Hosp Pharm       Date:  2013-11

3.  Influenza vaccination in north Indian patients with heart failure.

Authors:  Parvaiz A Koul; Saima Ali; Hyder Mir; Syed J Ahmad; Shabir Akram Bhat; Muneer A Bhat
Journal:  Indian Heart J       Date:  2016-07-30

4.  Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study.

Authors:  Paweł Rajewski; Dorota Zarębska-Michaluk; Ewa Janczewska; Andrzej Gietka; Włodzimierz Mazur; Magdalena Tudrujek-Zdunek; Krzysztof Tomasiewicz; Teresa Belica-Wdowik; Barbara Baka-Ćwierz; Dorota Dybowska; Waldemar Halota; Beata Lorenc; Marek Sitko; Aleksander Garlicki; Hanna Berak; Andrzej Horban; Iwona Orłowska; Krzysztof Simon; Łukasz Socha; Marta Wawrzynowicz-Syczewska; Jerzy Jaroszewicz; Zbigniew Deroń; Agnieszka Czauż-Andrzejuk; Jolanta Citko; Rafał Krygier; Anna Piekarska; Łukasz Laurans; Witold Dobracki; Jolanta Białkowska; Olga Tronina; Magdalena Wietlicka-Piszcz; Małgorzata Pawłowska; Robert Flisiak
Journal:  J Clin Med       Date:  2022-09-01       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.